TreeWAS – Variant ID: rs12946942

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
O03.4 Incomplete, without complication	0.012	0.988	0.000
O03.9 Complete or unspecified, without complication	0.011	0.989	0.000
O03 Spontaneous abortion	0.011	0.989	0.000
O03.8 Complete or unspecified, with other and unspecified complications	0.008	0.992	0.000
O03.7 Complete or unspecified, complicated by embolism	0.008	0.992	0.000
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.008	0.992	0.000
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.008	0.992	0.000
O03.3 Incomplete, with other and unspecified complications	0.008	0.992	0.000
O03.2 Incomplete, complicated by embolism	0.008	0.992	0.000
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.008	0.992	0.000
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.008	0.992	0.000
U80.1 Methicillin resistant agent	0.006	0.994	0.000
L29.9 Pruritus, unspecified	0.000	0.995	0.005
D22.5 Melanocytic naevi of trunk	0.000	0.995	0.005
U80 Agent resistant to penicillin and related antibiotics	0.005	0.995	0.000
D22.4 Melanocytic naevi of scalp and neck	0.000	0.995	0.005
U80.8 Agent resistant to other penicillin-related antibiotic	0.005	0.995	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
D22 Melanocytic naevi	0.000	0.995	0.005
L29.0 Pruritus ani	0.000	0.996	0.004
D50.8 Other iron deficiency anaemias	0.000	0.996	0.004
L29 Pruritus	0.000	0.996	0.004
D22.2 Melanocytic naevi of ear and external auricular canal	0.000	0.996	0.004
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.996	0.004
D22.9 Melanocytic naevi, unspecified	0.000	0.996	0.004
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.000	0.996	0.004
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.996	0.004
L29.2 Pruritus vulvae	0.000	0.996	0.004
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
D22.0 Melanocytic naevi of lip	0.000	0.996	0.003
D25.0 Submucous leiomyoma of uterus	0.000	0.996	0.004
D22.6 Melanocytic naevi of upper limb, including shoulder	0.000	0.996	0.003
D22.7 Melanocytic naevi of lower limb, including hip	0.000	0.997	0.003
I65.2 Occlusion and stenosis of carotid artery	0.003	0.997	0.000
L29.8 Other pruritus	0.000	0.997	0.003
L29.3 Anogenital pruritus, unspecified	0.000	0.997	0.003
L29.1 Pruritus scroti	0.000	0.997	0.003
M24.16 Other articular cartilage disorders (Lower leg)	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
U80.0 Penicillin resistant agent	0.003	0.997	0.000
D22.3 Melanocytic naevi of other and unspecified parts of face	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.003	0.997	0.000
D50 Iron deficiency anaemia	0.000	0.997	0.003
N92.0 Excessive and frequent menstruation with regular cycle	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
H66.9 Otitis media, unspecified	0.000	0.997	0.003
A41.8 Other specified septicaemia	0.003	0.997	0.000
H02.8 Other specified disorders of eyelid	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
B44.1 Other pulmonary aspergillosis	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.003	0.997	0.000
T42.1 Iminostilbenes	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.003	0.997	0.000
D25.2 Subserosal leiomyoma of uterus	0.000	0.997	0.003
J02.9 Acute pharyngitis, unspecified	0.000	0.997	0.003
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.997	0.000
T46.7 Peripheral vasodilators	0.002	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
T46.1 Calcium-channel blockers	0.002	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.000	0.997	0.003
A41 Other septicaemia	0.003	0.997	0.000
H18.8 Other specified disorders of cornea	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.997	0.000
U50 Level of care administered to neonates	0.002	0.997	0.000
U07 Emergency use of U07	0.002	0.997	0.000
U06 Emergency use of U06	0.002	0.997	0.000
U04 Severe acute respiratory syndrome [SARS]	0.002	0.997	0.000
U52 First in a series of a regular day/night admissions	0.002	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
T40.4 Other synthetic narcotics	0.002	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
M54.57 Low back pain (Lumbosacral region)	0.003	0.997	0.000
D50.1 Sideropenic dysphagia	0.000	0.997	0.002
A41.9 Septicaemia, unspecified	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
H18.2 Other corneal oedema	0.002	0.997	0.000
D61.9 Aplastic anaemia, unspecified	0.002	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.997	0.000
T42.3 Barbiturates	0.002	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.997	0.000
T42.0 Hydantoin derivatives	0.002	0.997	0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
U81.0 Vancomycin resistant agent	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
Z29.1 Prophylactic immunotherapy	0.000	0.998	0.002
H66 Suppurative and unspecified otitis media	0.000	0.998	0.002
Z73.3 Stress, not elsewhere classified	0.002	0.998	0.000
H66.3 Other chronic suppurative otitis media	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.002	0.998	0.000
I74 Arterial embolism and thrombosis	0.000	0.998	0.002
M24.1 Other articular cartilage disorders	0.002	0.998	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.998	0.002
R22.0 Localised swelling, mass and lump, head	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T36.0 Penicillins	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
U51 Admission status on psychiatric patients	0.002	0.998	0.000
D62 Acute posthaemorrhagic anaemia	0.002	0.998	0.000
B44.9 Aspergillosis, unspecified	0.002	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.002	0.998	0.000
B44 Aspergillosis	0.002	0.998	0.000
H18 Other disorders of cornea	0.002	0.998	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
A41.4 Septicaemia due to anaerobes	0.002	0.998	0.000
A41.3 Septicaemia due to Haemophilus influenzae	0.002	0.998	0.000
C83.3 Large cell (diffuse)	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.002	0.998	0.000
U06.9 Emergency use of U06.9	0.002	0.998	0.000
U06.8 Emergency use of U06.8	0.002	0.998	0.000
U06.7 Emergency use of U06.7	0.002	0.998	0.000
U06.6 Emergency use of U06.6	0.002	0.998	0.000
U06.5 Emergency use of U06.5	0.002	0.998	0.000
U06.4 Emergency use of U06.4	0.002	0.998	0.000
U06.3 Emergency use of U06.3	0.002	0.998	0.000
U06.2 Emergency use of U06.2	0.002	0.998	0.000
U06.1 Emergency use of U06.1	0.002	0.998	0.000
U06.0 Emergency use of U06.0	0.002	0.998	0.000
U07.9 Emergency use of U07.9	0.002	0.998	0.000
U07.8 Emergency use of U07.8	0.002	0.998	0.000
U07.7 Emergency use of U07.7	0.002	0.998	0.000
U07.6 Emergency use of U07.6	0.002	0.998	0.000
U07.5 Emergency use of U07.5	0.002	0.998	0.000
U07.4 Emergency use of U07.4	0.002	0.998	0.000
U07.3 Emergency use of U07.3	0.002	0.998	0.000
U07.2 Emergency use of U07.2	0.002	0.998	0.000
U07.1 Emergency use of U07.1	0.002	0.998	0.000
U07.0 Emergency use of U07.0	0.002	0.998	0.000
U50.9 Inquest Adjourned Death	0.002	0.998	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.002	0.998	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.002	0.998	0.000
U50.1 Level of care administered to neonates (Special Care)	0.002	0.998	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.002	0.998	0.000
M24.17 Other articular cartilage disorders (Ankle and foot)	0.002	0.998	0.000
A41.2 Septicaemia due to unspecified staphylococcus	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
B37.0 Candidal stomatitis	0.002	0.998	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
D25 Leiomyoma of uterus	0.000	0.998	0.002
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.002	0.998	0.000
D75.1 Secondary polycythaemia	0.000	0.998	0.002
N76.4 Abscess of vulva	0.000	0.998	0.002
A41.1 Septicaemia due to other specified staphylococcus	0.002	0.998	0.000
C82.2 Large cell, follicular	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
A41.0 Septicaemia due to Staphylococcus aureus	0.002	0.998	0.000
U88 Agent resistant to multiple antibiotics	0.002	0.998	0.000
H66.4 Suppurative otitis media, unspecified	0.000	0.998	0.002
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.998	0.002
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.998	0.002
H66.0 Acute suppurative otitis media	0.000	0.998	0.002
N73 Other female pelvic inflammatory diseases	0.000	0.998	0.002
U89 Agent resistant to other and unspecified antibiotics	0.002	0.998	0.000
Chapter XXII Codes for special purposes	0.002	0.998	0.000
H18.9 Disorder of cornea, unspecified	0.002	0.998	0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.002	0.998	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.002	0.998	0.000
I65.1 Occlusion and stenosis of basilar artery	0.002	0.998	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.002	0.998	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.000	0.998	0.002
O26.9 Pregnancy-related condition, unspecified	0.002	0.998	0.000
I74.8 Embolism and thrombosis of other arteries	0.000	0.998	0.002
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.998	0.002
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.998	0.002
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.998	0.002
U89.8 Agent resistant to other single specified antibiotic	0.002	0.998	0.000
N76 Other inflammation of vagina and vulva	0.000	0.998	0.002
M24.19 Other articular cartilage disorders (Site unspecified)	0.002	0.998	0.000
M24.18 Other articular cartilage disorders (Other)	0.002	0.998	0.000
M24.14 Other articular cartilage disorders (Hand)	0.002	0.998	0.000
M24.12 Other articular cartilage disorders (Upper arm)	0.002	0.998	0.000
M24.10 Other articular cartilage disorders (Multiple sites)	0.002	0.998	0.000
H18.4 Corneal degeneration	0.002	0.998	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.002	0.998	0.000
D61 Other aplastic anaemias	0.002	0.998	0.000
M81.40 Drug-induced osteoporosis (Multiple sites)	0.002	0.998	0.000
H06.2 Dysthyroid exophthalmos	0.002	0.998	0.000
N73.6 Female pelvic peritoneal adhesions	0.000	0.998	0.002
B44.8 Other forms of aspergillosis	0.002	0.998	0.000
B44.7 Disseminated aspergillosis	0.002	0.998	0.000
B44.2 Tonsillar aspergillosis	0.002	0.998	0.000
B44.0 Invasive pulmonary aspergillosis	0.002	0.998	0.000
H18.7 Other corneal deformities	0.002	0.998	0.000
H18.3 Changes in corneal membranes	0.002	0.998	0.000
H18.1 Bullous keratopathy	0.002	0.998	0.000
H18.0 Corneal pigmentations and deposits	0.002	0.998	0.000
Z29.8 Other specified prophylactic measures	0.000	0.998	0.002
Z29 Need for other prophylactic measures	0.000	0.998	0.002
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.000	0.998	0.002
N76.8 Other specified inflammation of vagina and vulva	0.000	0.998	0.002
M24.2 Disorder of ligament	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
D36 Benign neoplasm of other and unspecified sites	0.000	0.998	0.002
M24.21 Disorder of ligament (Shoulder region)	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
M24.11 Other articular cartilage disorders (Shoulder region)	0.002	0.998	0.000
N75.1 Abscess of Bartholin's gland	0.000	0.998	0.002
N76.2 Acute vulvitis	0.000	0.998	0.002
M24.13 Other articular cartilage disorders (Forearm)	0.002	0.998	0.000
C83.1 Small cleaved cell (diffuse)	0.002	0.998	0.000
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.002	0.998	0.000
M24.23 Disorder of ligament (Forearm)	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.002	0.998	0.000
U84 Resistance to other antimicrobial drugs	0.002	0.998	0.000
U83 Resistance to other antibiotics	0.002	0.998	0.000
U82 Resistance to betalactam antibiotics	0.002	0.998	0.000
U85 Resistance to antineoplastic drugs	0.002	0.998	0.000
G44.2 Tension-type headache	0.002	0.998	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.001	0.998	0.000
O32.1 Maternal care for breech presentation	0.002	0.998	0.000
R07.2 Precordial pain	0.002	0.998	0.000
M24.24 Disorder of ligament (Hand)	0.002	0.998	0.000
T40.2 Other opioids	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
M45 Ankylosing spondylitis	0.002	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.998	0.002
Z73.8 Other problems related to life-management difficulty	0.002	0.998	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.000	0.998	0.002
N73.5 Female pelvic peritonitis, unspecified	0.000	0.998	0.002
N73.4 Female chronic pelvic peritonitis	0.000	0.998	0.002
N73.3 Female acute pelvic peritonitis	0.000	0.998	0.002
N73.2 Unspecified parametritis and pelvic cellulitis	0.000	0.998	0.002
N73.1 Chronic parametritis and pelvic cellulitis	0.000	0.998	0.002
N73.0 Acute parametritis and pelvic cellulitis	0.000	0.998	0.002
U89.9 Agent resistant to unspecified antibiotic	0.001	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.002	0.998	0.000
H18.5 Hereditary corneal dystrophies	0.002	0.998	0.000
I74.5 Embolism and thrombosis of iliac artery	0.000	0.998	0.002
M24.5 Contracture of joint	0.002	0.998	0.000
O20.8 Other haemorrhage in early pregnancy	0.002	0.998	0.000
O63.9 Long labour, unspecified	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
N76.5 Ulceration of vagina	0.000	0.998	0.002
N76.3 Subacute and chronic vulvitis	0.000	0.998	0.002
N76.1 Subacute and chronic vaginitis	0.000	0.998	0.002
M24 Other specific joint derangements	0.002	0.998	0.000
Z73 Problems related to life-management difficulty	0.002	0.998	0.000
M24.55 Contracture of joint (Pelvic region and thigh)	0.002	0.998	0.000
S42.30 Fracture of shaft of humerus (closed)	0.002	0.998	0.000
D61.8 Other specified aplastic anaemias	0.001	0.998	0.000
D61.3 Idiopathic aplastic anaemia	0.001	0.998	0.000
D61.2 Aplastic anaemia due to other external agents	0.001	0.998	0.000
D61.1 Drug-induced aplastic anaemia	0.001	0.998	0.000
D61.0 Constitutional aplastic anaemia	0.001	0.998	0.000
N76.0 Acute vaginitis	0.000	0.998	0.002
D25.9 Leiomyoma of uterus, unspecified	0.000	0.998	0.002
G51.0 Bell's palsy	0.002	0.998	0.000
H18.6 Keratoconus	0.001	0.998	0.000
D36.7 Other specified sites	0.000	0.998	0.002
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.002	0.998	0.000
Z29.9 Prophylactic measure, unspecified	0.000	0.998	0.001
M24.29 Disorder of ligament (Site unspecified)	0.001	0.998	0.000
M24.28 Disorder of ligament (Other)	0.001	0.998	0.000
M24.25 Disorder of ligament (Pelvic region and thigh)	0.001	0.998	0.000
M24.22 Disorder of ligament (Upper arm)	0.001	0.998	0.000
M24.20 Disorder of ligament (Multiple sites)	0.001	0.998	0.000
D36.9 Benign neoplasm of unspecified site	0.000	0.998	0.001
D36.0 Lymph nodes	0.000	0.998	0.001
H22.1 Iridocyclitis in other diseases classified elsewhere	0.002	0.998	0.000
N76.6 Ulceration of vulva	0.000	0.998	0.001
H25.8 Other senile cataract	0.000	0.998	0.002
M19.94 Arthrosis, unspecified (Hand)	0.002	0.998	0.000
M24.26 Disorder of ligament (Lower leg)	0.001	0.998	0.000
M24.4 Recurrent dislocation and subluxation of joint	0.002	0.998	0.000
O32.0 Maternal care for unstable lie	0.002	0.998	0.000
M24.51 Contracture of joint (Shoulder region)	0.001	0.998	0.000
Z73.9 Problem related to life-management difficulty, unspecified	0.002	0.998	0.000
J02 Acute pharyngitis	0.000	0.998	0.002
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.001	0.998	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.001	0.998	0.000
U82.8 Resistance to other betalactam antibiotics	0.001	0.998	0.000
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.001	0.998	0.000
U82.1 Resistance to methicillin	0.001	0.998	0.000
U82.0 Resistance to penicillin	0.001	0.998	0.000
U83.9 Resistance to unspecified antibiotic	0.001	0.998	0.000
U83.8 Resistance to other single specified antibiotic	0.001	0.998	0.000
U83.7 Resistance to multiple antibiotics	0.001	0.998	0.000
U83.2 Resistance to quinolones	0.001	0.998	0.000
U83.1 Resistance to other vancomycin related antibiotics	0.001	0.998	0.000
U83.0 Resistance to vancomycin	0.001	0.998	0.000
U84.9 Resistance to unspecified antimicrobial drugs	0.001	0.998	0.000
U84.8 Resistance to other specified antimicrobial drug	0.001	0.998	0.000
U84.7 Resistance to multiple antimicrobial drugs	0.001	0.998	0.000
U84.3 Resistance to tuberculostatic drug(s)	0.001	0.998	0.000
U84.2 Resistance to antiviral drug(s)	0.001	0.998	0.000
U84.1 Resistance to antifungal drug(s)	0.001	0.998	0.000
U84.0 Resistance to antiparasitic drug(s)	0.001	0.998	0.000
M24.27 Disorder of ligament (Ankle and foot)	0.001	0.998	0.000
M24.47 Recurrent dislocation and subluxation of joint (Ankle and foot)	0.001	0.998	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
T50.9 Other and unspecified drugs, medicaments and biological substances	0.001	0.998	0.000
C83.7 Burkitt's tumour	0.001	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.001	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.001	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.001	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.001	0.998	0.000
M24.3 Pathological dislocation and subluxation of joint, not elsewhere classified	0.001	0.998	0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.001	0.998	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.001	0.998	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.001	0.998	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.001	0.998	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.001	0.998	0.000
M45.X2 Ankylosing spondylitis (Cervical region)	0.001	0.998	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.001	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.001	0.998	0.000
H61.0 Perichondritis of external ear	0.001	0.998	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.998	0.001
H21 Other disorders of iris and ciliary body	0.001	0.998	0.000
M24.59 Contracture of joint (Site unspecified)	0.001	0.998	0.000
M24.58 Contracture of joint (Other)	0.001	0.998	0.000
M24.57 Contracture of joint (Ankle and foot)	0.001	0.998	0.000
M24.56 Contracture of joint (Lower leg)	0.001	0.998	0.000
M24.54 Contracture of joint (Hand)	0.001	0.998	0.000
M24.53 Contracture of joint (Forearm)	0.001	0.998	0.000
M24.52 Contracture of joint (Upper arm)	0.001	0.998	0.000
M24.50 Contracture of joint (Multiple sites)	0.001	0.998	0.000
O32.8 Maternal care for other malpresentation of foetus	0.001	0.998	0.000
Q66.8 Other congenital deformities of feet	0.001	0.998	0.000
Z03.4 Observation for suspected myocardial infarction	0.000	0.998	0.002
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.001	0.998	0.000
O00-O08 Pregnancy with abortive outcome	0.001	0.998	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.001	0.999	0.000
L60.0 Ingrowing nail	0.000	0.999	0.001
M24.9 Joint derangement, unspecified	0.001	0.999	0.000
M24.7 Protrusio acetabuli	0.001	0.999	0.000
M24.6 Ankylosis of joint	0.001	0.999	0.000
Z73.6 Limitation of activities due to disability	0.001	0.999	0.000
Z73.5 Social role conflict, not elsewhere classified	0.001	0.999	0.000
Z73.4 Inadequate social skills, not elsewhere classified	0.001	0.999	0.000
Z73.2 Lack of relaxation and leisure	0.001	0.999	0.000
Z73.1 Accentuation of personality traits	0.001	0.999	0.000
Z73.0 Burn-out	0.001	0.999	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.000	0.999	0.001
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.999	0.001
N75 Diseases of Bartholin's gland	0.000	0.999	0.001
D60-D64 Aplastic and other anaemias	0.001	0.999	0.000
R22.3 Localised swelling, mass and lump, upper limb	0.000	0.999	0.001
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.999	0.001
M24.49 Recurrent dislocation and subluxation of joint (Site unspecified)	0.001	0.999	0.000
M24.48 Recurrent dislocation and subluxation of joint (Other)	0.001	0.999	0.000
M24.46 Recurrent dislocation and subluxation of joint (Lower leg)	0.001	0.999	0.000
M24.45 Recurrent dislocation and subluxation of joint (Pelvic region and thigh)	0.001	0.999	0.000
M24.44 Recurrent dislocation and subluxation of joint (Hand)	0.001	0.999	0.000
M24.43 Recurrent dislocation and subluxation of joint (Forearm)	0.001	0.999	0.000
M24.42 Recurrent dislocation and subluxation of joint (Upper arm)	0.001	0.999	0.000
M24.40 Recurrent dislocation and subluxation of joint (Multiple sites)	0.001	0.999	0.000
I77.9 Disorder of arteries and arterioles, unspecified	0.000	0.999	0.001
N92.5 Other specified irregular menstruation	0.000	0.999	0.001
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.999	0.001
H71 Cholesteatoma of middle ear	0.000	0.999	0.001
N70-N77 Inflammatory diseases of female pelvic organs	0.000	0.999	0.001
M24.37 Pathological dislocation and subluxation of joint, not elsewhere classified (Ankle and foot)	0.001	0.999	0.000
J02.8 Acute pharyngitis due to other specified organisms	0.000	0.999	0.001
J02.0 Streptococcal pharyngitis	0.000	0.999	0.001
M81.4 Drug-induced osteoporosis	0.001	0.999	0.000
T63.4 Venom of other arthropods	0.001	0.999	0.000
Z93.2 Ileostomy status	0.001	0.999	0.000
Q66.3 Other congenital varus deformities of feet	0.001	0.999	0.000
O32 Maternal care for known or suspected malpresentation of foetus	0.001	0.999	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.001	0.999	0.000
M19.01 Primary arthrosis of other joints (Shoulder region)	0.001	0.999	0.000
M24.39 Pathological dislocation and subluxation of joint, not elsewhere classified (Site unspecified)	0.001	0.999	0.000
M24.38 Pathological dislocation and subluxation of joint, not elsewhere classified (Other)	0.001	0.999	0.000
M24.36 Pathological dislocation and subluxation of joint, not elsewhere classified (Lower leg)	0.001	0.999	0.000
M24.35 Pathological dislocation and subluxation of joint, not elsewhere classified (Pelvic region and thigh)	0.001	0.999	0.000
M24.34 Pathological dislocation and subluxation of joint, not elsewhere classified (Hand)	0.001	0.999	0.000
M24.33 Pathological dislocation and subluxation of joint, not elsewhere classified (Forearm)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations